These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 16647513

  • 1. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
    Roque J, Rios G, Humeres R, Volpi C, Herrera JM, Schultz M, Rios H, Rius M, Salgado C, Hepp J.
    Transplant Proc; 2006 Apr; 38(3):930-1. PubMed ID: 16647513
    [Abstract] [Full Text] [Related]

  • 2. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 3. Posttransplantation lymphoproliferative disorder in pediatric liver transplantation.
    Heo JS, Park JW, Lee KW, Lee SK, Joh JW, Kim SJ, Lee HH, Lee DS, Choi SH, Seo JM, Choe YH.
    Transplant Proc; 2004 Oct; 36(8):2307-8. PubMed ID: 15561231
    [Abstract] [Full Text] [Related]

  • 4. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 6. The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients.
    Ozçay F, Arslan H, Bilezikçi B, Sevmiş S, Moray G, Haberal M.
    Transplant Proc; 2009 Sep; 41(7):2878-80. PubMed ID: 19765462
    [Abstract] [Full Text] [Related]

  • 7. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
    D'Antiga L, Del Rizzo M, Mengoli C, Cillo U, Guariso G, Zancan L.
    Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
    [Abstract] [Full Text] [Related]

  • 8. Posttransplant lymphoproliferative disorders in transplant recipients.
    Timurağaoğlu A, Uğur-Bilgin A, Colak D, Tuncer M, Gölbaşi I, Hazar V, Kiliçarsłan B, Undar L, Demirbaş A.
    Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
    [Abstract] [Full Text] [Related]

  • 9. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
    Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC.
    J Clin Oncol; 2005 Sep 20; 23(27):6481-8. PubMed ID: 16170157
    [Abstract] [Full Text] [Related]

  • 10. Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients.
    Krieger NR, Martinez OM, Krams SM, Cox K, So S, Esquivel CO.
    Liver Transpl; 2000 Jan 20; 6(1):62-6. PubMed ID: 10648579
    [Abstract] [Full Text] [Related]

  • 11. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.
    Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
    Kim JM, Lee SK, Kim SJ, Joh JW, Kwon CH, Choe YH, Shin M, Kim EY, Moon JI, Jung GO, Choi GS.
    Transplant Proc; 2010 Apr 15; 42(3):895-9. PubMed ID: 20430199
    [Abstract] [Full Text] [Related]

  • 13. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
    Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW.
    Transplantation; 2003 Apr 15; 75(7):987-93. PubMed ID: 12698085
    [Abstract] [Full Text] [Related]

  • 14. Burkitt's lymphoma following a pediatric liver transplantation: predictive negative value of serologic response to Epstein-Barr virus.
    Yilmaz A, Hazar V, Akçam M, Inanç-Gürer E, Ceken K, Artan R.
    Turk J Pediatr; 2007 Apr 15; 49(4):434-6. PubMed ID: 18246749
    [Abstract] [Full Text] [Related]

  • 15. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.
    McDiarmid SV, Jordan S, Kim GS, Toyoda M, Goss JA, Vargas JH, Martín MG, Bahar R, Maxfield AL, Ament ME, Busuttil RW.
    Transplantation; 1998 Dec 27; 66(12):1604-11. PubMed ID: 9884246
    [Abstract] [Full Text] [Related]

  • 16. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML, Tannuri U, Tannuri AC, Mello ES, Lima F, Gibelli NE, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Andrade WC, Miyatani HT.
    Transplant Proc; 2010 Jun 27; 42(5):1763-8. PubMed ID: 20620519
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction.
    Kullberg-Lindh C, Ascher H, Saalman R, Olausson M, Lindh M.
    Pediatr Transplant; 2006 Feb 27; 10(1):83-9. PubMed ID: 16499593
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of posttransplantation lymphoproliferative disease in pediatric liver transplant recipients.
    Wiederkehr JC, Coelho IM, Avilla SG, e Silva EM, Schuller S, Ouno DD, Wiederkehr BA, Polimeni M.
    Transplant Proc; 2010 Mar 27; 42(2):521-2. PubMed ID: 20304183
    [Abstract] [Full Text] [Related]

  • 19. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 20. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME.
    Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.